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Omics approaches (e.g. transcriptomics, metabolomics) are promising for ecological risk assessment 
(ERA) since they provide mechanistic information and early warning signals. A crucial step in the 
analysis of omics data is the modelling of concentration-dependency which may have different trends 
including monotonic (e.g. linear, exponential) or biphasic (e.g. U shape, bell shape) forms. The diversity 
of responses raises challenges concerning detection and modelling of significant responses and effect 
concentration (EC) derivation. Furthermore, handling high-throughput datasets is time-consuming and 
requires effective and automated processing routines. Thus, we developed an open source tool (DRomics, 
available as an R-package and as a web-based service) which, after elimination of molecular responses 
(e.g. gene expressions from microarrays) with no concentration-dependency and/or high variability, 
identifies the best model for concentration-response curve description. Subsequently, an EC (e.g. a 
benchmark dose) is estimated from each curve and curves are classified based on their model parameters. 
This tool is especially dedicated to manage data obtained from an experimental design favoring a great 
number of tested doses rather than a great number of replicates and also to handle properly monotonic and 







Ecological risk assessment (ERA) is defined as a procedure which estimates the probability that one or 
several stressors induce ecological adverse effects
1
, and which aims to support decision making
2
. ERA 
mainly relies on the estimation of effect concentration (EC, e.g. ECx, the concentration which affects an 
endpoint at x percent of the maximal effect, or BMD, the benchmark dose or concentration) obtained 
from concentration-response curves (CRC). Subsequently, the ECs can be used for further assessments 
such as Risk Quotients (PEC/PNEC)
3
 or sensitivity distributions
4
. Deriving ECs from raw data constitutes 
a critical step which requires dedicated approaches. Before the recent rise of omics (e.g. genomics, 
transcriptomics), ERA was mainly performed on the response of apical endpoints (e.g. mortality, growth, 
photosynthesis inhibition). Those endpoints mostly follow a sigmoidal CRC and appropriate approaches 
(PROAST software: www.rivm.nl/proast, DRC package
5
) were developed to model such responses and 
calculate ECs. In the recent years, toxicogenomics approaches were established to support the ERA-
processes. The data obtained from such approaches showed that the sigmoidal trend is rather the 
exception than the rule
6,7
. Molecular responses can be monotonic but following other than sigmoidal 
trends or even non-monotonic. Hence, estimating ECs from omics data requires a robust tool that can 
automatically handle high-throughput data, capture and model various and complex trends, and calculate 
ECs from such complex responses. Obtaining ECs based on omics data, comparable to those obtained 
from apical endpoints, is a challenge.  
Various attempts have been made to manage omics data in a dose-response framework by addressing 
the previously stated requirements
6–12
. These studies present interesting approaches but several crucial 
steps rely on methods presenting some limitations for a dose-response framework (e.g. normalization, 
preselection of data with concentration dependency and low variability, models) that can lead to a loss of 
meaningful biological information. For example, many routines begin with a step detecting the 
significantly responding data (e.g. genes showing a concentration-dependent change) using a one-way 
ANOVA-based selection or similar method
6–8,11
 aiming at comparing a small number of groups with 





(concentration series with a small number of replicates per concentration)
13
. Other methods proposed for 
analysis of concentration-response data
14,15
 only consider monotonic CRCs and hence, would miss/discard 
molecular responses displaying common biphasic (U shape, bell shape) CRCs. Often, the CRC modelling 
step compares different potential models by curve fitting based on non-linear regression and the model 
with the best fit is selected to describe the CRC
6–8,11
. However, not all of the approaches allowed deriving 
an EC, which would represent a crucial step in case of the use of toxicogenomics data for subsequent 
ERA. Furthermore, the robustness of an EC derivation from such data was never studied. 
 
The aim of this study was to develop a workflow and a tool to facilitate the use of high-throughput 
omics data in ERA by providing reliable ECs. This workflow was designed to handle the various steps of 
omics data processing in a concentration (as well as dose)-response framework and is already provided as 
an open source software (DRomics) via an online interface and an R package. Our objectives were to 
provide a tool that enables to (1) normalize data, (2) select both monotonic and biphasic responses, (3) 
model CRCs for significant responses and choose the best fitting model (based on a reduced, essential set 
of models with a limited number of parameters, but allowing to capture a great diversity of trends), (4) 
characterize the shape of CRCs and (5) derive an EC from each CRC whatever its shape is. The DRomics 
tool is inspired from a previous workflow developed by Smetanova et al.
7
, but proposes the improvement 
of steps 2 and 3 and the addition of steps 4 and 5. We especially paid attention to the repeatability of the 
results to assess the robustness of the whole approach. To exemplify our approach, we worked on a 
microarray-based transcriptomic dataset of the green algae Scenedesmus vacuolatus exposed to triclosan. 
 
DATA 
Scenedesmus vacuolatus transcriptomics response analysis 
Cultures of chlorophyte S. vacuolatus were exposed for 14 hours to five concentrations of triclosan in 
the range of 0.69- 6.63µg/L (SI section S1). After sampling, the RNA was extracted, labelled and 





commercial microarray was available for this species, the microarray was designed based on a former 
RNA sequencing (SI section S1). Briefly, 21,495 contigs (minimum length 100 bases) were selected to 
design an 8X60 K microarray using eArray (Agilent Technologies, Böblingen, Germany). Each contig 
was represented by one or two probes in the microarray and overall 18,562 probes were replicated. The 
final dataset contains the fluorescence value of 61,535 probes (18,562 probes present twice and 24,411 
present only once) for 6 treatments in 5 replicates.  
 
DEVELOPMENT OF THE DROMICS TOOL  
The TOC illustrates an overview of the main steps handled by the DRomics tool. DRomics has been 
released as an R package (https://lbbe.univ-lyon1.fr/-DRomics-.html) and a user-friendly online 
application is also available (http://lbbe-shiny.univ-lyon1.fr/DRomics-shiny/). Its workflow is organized 
in four steps described thereafter. 
 
Step 1: Inter-array normalization  
As a first step, the log2 fluorescence values of the microarray dataset were normalized (between arrays) 
in order to counterbalance for differences in hybridization efficacy. The limma R package
16
, which is 
dedicated to deal with microarray data, proposes three options to normalize single-channel data using the 
function “normalizeBetweenArrays”: quantile, scale and cyclic loess. Briefly, the quantile normalization 
forces the entire empirical distributions of each array to be identical while the scale method forces only 
the medians of each array to be the same. The cyclic loess method, which is more sophisticated and more 
time consuming, is based on the repetition on each pair of arrays of a loess regression between the 
difference of expression between the two arrays and the average expression
17
. We compared the three 
different approaches for Scenedesmus microarray data and the effect of normalization on the distributions 
of the gene expression values for each array (Figure S2). With the scale method high differences were 
observed for high fluorescence values, with some values clearly exceeding the maximum level of raw 





extreme values on CRC trends. The cyclic loess and the quantile methods are known to reveal similar 
results. However, the cyclic loess was giving a less aggressive (i.e. weaker deformation) and more robust 
transformation of raw data
16,17
, as illustrated in Figure S2. The quantile method is sometimes preferred 
since it is less time consuming. Hence, as the normalization step was not the rate limiting step in the data 
analysis in comparison to the other steps of our workflow, the cyclic loess method was chosen for the 
following analysis. However, the DRomics tool would nevertheless offer the opportunity to apply one of 
the other methods. 
 
Step 2: Selection of the responsive molecular data  
Datasets obtained from omics-approaches are typically large, representing thousands of genes 
and not all them respond to a concentration gradient of an exposure chemical. Therefore, we implemented 
a filtering step which aimed to identify significantly responding genes to the stressor, in order to focus 
only on the genes of interest, to reduce computational effort for modelling CRCs, and as recommended by 
Webster et al. 
18
 to improve the biological relevance of derived EC values. Our purpose was to provide an 
approach adapted to handle dose or concentration-response data which (1) does not require many 
replicates for each tested concentration (and hence was more powerful than the classically used ANOVA-
based method
13
) and (2) is able to detect both monotonic and biphasic CRCs. Tukey et al.
19
 proposed a 
trend test to detect monotonic trends by testing the significance of a regression line linking the response to 
the concentration in raw scale, log-scale or rank-scale. Assuming that the tested concentrations are well 
placed within the design, we favored the rank scale. Furthermore, in order to extend Tukey’s trend test to 
the detection of biphasic trends, we tested the global significance of a first order polynomial curve 
(regression line) and of a second order polynomial curve (quadratic curve). The 3 approaches (ANOVA-
test, linear trend test and quadratic trend test) were implemented in DRomics using the limma R package 
and compared. A Benjamini-Hochberg correction on the p-values was applied in order to control the false 
discovery rate associated to such a big dataset. A default threshold value of 0.05 was fixed for the false 





Based on the microarray dataset consisting of 61,535 probes with 5 replicates per condition, the 
quadratic trend test detected the highest number of responsive probes (n=13,182) compared to the 
ANOVA test (n=8,755) and the linear trend test (n=5,790) (Figure 1A). In Figure 1 the numbers of 
selected genes are reported in the caption. More than ninety percent of the probes which were detected by 
both ANOVA and linear trend test were also detected by the quadratic trend test. In contrast, the quadratic 
trend test allowed detecting a considerably higher number of probes if compared to the two other tests. In 
order to compare the three approaches in situations with a low number of replicates per condition, the 
same procedure was applied but on only three or two out of the total of five replicates (Figure 1B and 
Figure 1C). The superiority of the quadratic trend test on the two other methods clearly appears when the 
number of replicates is low (Figure 1B and 1C). With only 2 replicates, the ANOVA test method was 
unable to select any responsive probe. In the present study, the preselection of genes responsive to 
triclosan was conducted based on the quadratic model alone for the following analysis, but the DRomics 
tool proposes the three described methods. 
 
Step 3: Response modelling and selection of the best model 
In order to select appropriate approaches for CRC modelling, we first visually examined a random set 
of probes (ca. a thousand) in order to detect the major trend models. Considering monotonic CRCs, we 
found only a minority of increasing or decreasing sigmoid curves that could be described using the 
classical Hill model (Table 1 and Figure 2, panels H.inc and H.dec). We did not consider any other 
sigmoid model in the set of models as it was already demonstrated that the different models result in very 
similar fits
7,20
 and that the choice of the sigmoid model had not a great impact on the determination of 
ECs
21
.  The other observed monotonic trends were increasing or decreasing linear curves (Figure 2, panels 
L.inc and L.dec - simply described by a linear model) or increasing or decreasing curves with an 
asymptote only at low (Figure 2,  panels E.inc.convex and E.dec.concave) or high concentrations (Figure 





model (Table 1). Depending of the signs of its parameters b and e this model is able to describe the four 
observed trends with a flexible curvature controlled by both parameters b and e. 
For biphasic CRCs, our objective was to be able to describe all type of observed biphasic trends in a 
robust way, with models strictly increasing (or descreasing, respectively) before reaching the maximal 
(resp. minimal) signal and then strictly decreasing (or increasing,  respectively) (Figure 2 panels GP.bell 
and lGP.bell and GP.U and lGP.U, respectively). We also wanted to be able to describe asymptotes at low 
and/or high concentrations with potentially different levels for both asymptotes (Figure 2 panel GP.bell). 
For modelling of biphasic concentration-response curves many complex models were already proposed, 
usually outside the context of omics data and often associated with limitations. This is due to their 
complexity and too high flexibility, indicating a need to develop new mathematical models
22
. In the 
context of omics data, mainly second and third order polynomial models and Gaussian type models were 
proposed to describe biphasic trends. We used a Gaussian type model since polynomial models cannot 
describe asymptotes. Moreover, third polynomial models have more than two phases and may thus take 
unwanted forms (non-biphasic). However, available Gaussian models have the same asymptotic levels at 
low and at high concentrations. Therefore, two new 5-parameter models (Gaussian-probit and log-
Gaussian-probit models, Table 1) were built by addition of a probit component with two asymptotic 
levels d and c to a Gaussian part (in log-scale for the log-Gaussian-probit model) of amplitude f, with 
parameters b and e shared by both parts (see a schematic description of the Gaussian-probit model in 
Figure S3). For equal c and d values those two models respectively correspond to classical 4-parameter 
Gaussian and log-Gaussian models as used in Smetanova et al.
7
. For different c and d values they provide 
a simple extension enabling two different asymptotic levels as often encountered in our data set as in 
Figure 2, panels GP.U, GP.bell, lGP.U). As done by Smetanova et al.
7
 , we used two versions of this new 
Gaussian-probit model, for raw or log-scale data, in order to be able to describe symmetrical (models in 
raw scale) or asymetrical (models in log scale) shapes of curves around the local extremum. 
Models were fitted to each previously selected probe by nonlinear regression using the R function 





parameters and in their simplified form with 4 parameters (with d = c). The best-fit model was identified 
by the lowest Akaike Information Criterion (AIC). Probes for which the AIC value of the best model was 
not lower than the AIC value of the null model (constant model) minus 2 were considered as not 
exhibiting a concentration dependent trend and were eliminated from the probe set that was subjected to 
CRC modelling, as recommended by EFSA Scientific Committee
12
. Another filter was implemented to 
eliminate fits considered as not reliable. The filter was based on the test of global significance of a 
quadratic trend of the residuals as a function of the tested concentrations in rank-scale (similarly to the 
quadratic test used for the selection of responsive probes). If the trend on residuals is significant the 
model is not considered as reliably fitting the data and the probe is eliminated. On the 13,182 initially 
fitted CRCs, 1,116 (8.5%) failed to pass this significance test. Those 1,116 eliminated probes mainly 
correspond to very noisy data sets that would have been eliminated by the selection step if the false 
discovery rate was fixed to a smaller value (0.01 or 0.001 instead of 0.05) and to data sets for which the 
significant response was observed only at the highest tested concentration (two typical examples are given 
in Figure S4). In the latter case an exponential model could theoretically describe the curve, but there is 
not enough information in the data to estimate its curvature.  
For the other 12,066 fitted CRCs, the Gaussian-probit model was chosen as the best fit model for 
29.3% of the CRCs, followed by the linear model (26.5%), the exponential model (28.1%), the log-
Gaussian-probit model (14.6%) and the Hill model (1.5%). The distribution of those fits among the 12 
shapes described in Figure 2 (and supported by the models in the Table 1) is reported in the legend of 
Figure 2. From this classification in 12 shapes, the CRCs can be classified in four rough trends, increasing 
(30.7%), decreasing (25.4%), U-shape (24.7%) and bell-shape (19.2%) curves. The visual examination of 
each curve showed a good fit of the best-fit model. The fit is reported in Figure S5 for the first 49 selected 
probes (those with the most significant response).  
 





In this part, our objective was to define ECs consistent and commensurable for all previously selected 
probes accounting for all type of CRCs (sigmoidal, linear, exponential, biphasic (U or bell shape)).  
 
Effective Concentrations (which affect the endpoint at x% of the maximal effect, ECx) have now 
largely supplanted No Observed Effect Concentrations (NOEC), after decades of statistical criticisms 
towards the latter
23
. ECx has a simple definition which sounds unambiguous. However, depending on the 
CRC shape, its derivation is not trivial and must be paid attention. When using a sigmoidal CRC, the ECx 
is calculated as the concentration leading to x% of effect compared to the control and relatively to the 
amplitude of the response level between control and highest concentrations. For example, the EC50 in a 
Hill/log-logistic model is the abscissa of the inflection point of the CRC, but it is does not necessarily 
corresponds to half the control response level, unless the response level tends to zero at very high 
exposure concentrations. The derivation of an ECx does make sense only if an asymptotic response is 
observed at high exposure concentrations. For non-sigmoidal CRCs, as observed for gene expression, the 
calculation of such ECx is not possible and hence not suitable. 
 
Alternatively to ECx, the Benchmark Dose (BMD) has been proposed in the field of toxicology for 
setting ECs
24
. The BMD approach described in the EFSA guidance
12
 proposes two options. The first 
option considers an x-fold change of the control response which makes it equivalent to a x% 
inhibition/enhancement concentration. The so-called BMD-xfold was calculated as the concentration 
corresponding to a Benchmark Response (BMR-xfold) defined as follows: BMR-xfold = y0 +/- y0*x/100, 
where y0 is the mean control response and x is the percentage of change. However, such BMD-xfold 
seems hazardously sensitive to the signal level: if the control response is zero or a very low value, so will 
be the x-fold change. The BMD-xfold approach will lead to ECs closer to the control in contrast to cases 
with similar responses but high control levels. This is illustrated in Figure S6: both probes were described 
by the same CRC (linear with almost the same slope) whereas the BMD-10%fold is much lower in case 





critical response level accounting for the standard deviation of data around the mean CRC. This feature 
makes it more robust and usable whatever the CRC model chosen, hence this method was favored in our 
study. The so-called BMD-zSD detects the concentration leading to a level of change compared to the 
control response that takes data variability around the modelled curve into account. It was calculated as 
the concentration corresponding to a Benchmark Response (BMR-zSD) defined as follows: BMR-zSD = 
y0 +/- z*SD, where y0 is the mean control response, SD is the residual standard deviation of the 
considered CRC and z is the factor of SD. For linear, exponential and Hill CRCs, the BMD-xfold/BMD-
zSD can be analytically calculated by inversing model equations (Table 1). For biphasic CRCs, there may 
be two concentrations corresponding to the BMR. The BMD-xfold/BMD-zSD was defined as the lowest 
concentration corresponding to the BMR and it was sought numerically using the “uniroot” R function, 
first in the first increasing (resp. decreasing) phase and if not found in the first phase it was sought in the 
second decreasing (resp. increasing) phase. Both situations are illustrated in Figure S7.  
BMD-zSD for z=1 (value proposed in EFSA guidance
12
) and z=2 and BMD-xfold for x=5, 10 and 20% 
were calculated for every fitted CRC. In some cases the BMD cannot be estimated because it was beyond 
the tested concentration range or because the BMR stood outside the range of response values defined by 
the model. Hence BMD-5%fold (resp. -10%fold and -20%fold) could not be determined for 7.2% (resp. 
34.1% and 65.7%) of fitted CRCs and BMD-1SD (resp. -2SD) could not be determined for 0.5% (resp. 
37.3%) of fitted CRCs. On our data set, BMD-1SD corresponded to an average xfold change of 8.7% 
(interquartile range 3.4-11.4]%) (min-max [0.8-63.8]%), BMD-2SD to an average xfold change of 14.3% 
(interquartile range [5.9-17.4]%) (min-max [1.6-127.7]%). The distribution of all of the BMD-1SD values 
(as provided by the tool) is globally represented in Figure 3 and by model typology in Figure S8. Given 
the shape of models (Figure 2), we logically obtained high BMD-1SD values for decreasing concave and 
increasing convex exponential CRCs and low BMD-1SD values for decreasing convex and increasing 
concave exponential CRCs. Log-Gauss CRCs mostly corresponded to low BMD-1SD values, 93.1% of 
them being below the extremum For Gauss CRCs, 63.5% of BMD-1SD are below the extremum, which 





to visualize in the Figure because of a low occurrence. The second mode, about 6 µg/L, probably 
corresponded to Hill CRCs where the model fitting was mostly driven by the response at the highest 
exposure concentration (6.63 µg/L). For linear models, BMD-1SD distributions were bell-shaped and 
spread across the tested concentration range. 
 
Repeatability of the results 
In the studied data set, 18,562 probes were represented twice on the microarray, which enabled us to 
analyze the repeatability of the results of the workflow by comparison of the results obtained for two 
same probes. Using the quadratic selection with an FDR of 0.05, 71.6 % of the probes selected using 
replicate 1 were also selected using replicate 2 of those probes. This proportion is increasing when the 
FDR is decreased and is stabilizing around 78% for FDR values inferior or equal to 0.001. The two other 
selection methods (linear trend test and ANOVA test) gave very similar results (respectively 75% and 
76% for an FDR of 0.001). Using quadratic selection and an FDR of 0.05 the proportion of probes 
classified in the same trend (U, bell, increasing, decreasing) is 89%. This proportion is not much 
influenced by the FDR. 36% of the observed discordances correspond to replicates classified in bell or 
decreasing trend depending on the replicate (example of probe “13613” in Figure S9) and  50% of the 
discordances correspond to replicates classified in U or increasing trend depending on the replicate 
(example of probe “39905” in Figure S9). Strong differences between BMD values could be observed in 
such cases (probe “13613” and “39905” in Figure S9), but also with responses described with the same 
bi-phasic model: in few cases (see probe “23384” in Figure S9) the BMR can be reached in the first phase 
with one replicate and in the second for the other one. Globally, the Root Mean Square Error (RMSE: root 
mean squared differences between BMD-1SD values estimated for both replicates of each probe) was 
estimated at 1.198 for an FDR of 0.05 and 0.882 for an FDR of 0.001. This RMSE is increasing when the 
FDR is decreasing and is stabilizing below 0.9 for FDR values inferior to 0.001. For comparison, the 
repeatability of BMD-1SD values derivated from the same data set (replicated probes both selected with 





classified as biphasic by DRomics (RMSE of 1.803 for BMDExpress in comparison to 1.079 for 
DRomics) (see section S8 for details).    
 
DISCUSSION 
Recommendation for experimental design 
The quality of modelling a concentration-response curve is dependent of the information provided by 
the data set. Replicates enable to characterize the variability around the mean concentration-response. If 
resources are limited, one should favor the number of concentrations rather than the number of replicates, 
and try to equally spread a maximal number of concentrations on the whole range of the expected 
response.  This would not impair the precision of the residual standard deviation required for the BMD-
zSD calculation that only depends on the total number of points on the CRC. In our example, the design 
(6 concentrations with 5 replicates per concentration) was minimal to model the CRC, and it may have 
been advantageous to have a greater number of concentrations with two or three replicates per 
concentrations only. While building our workflow, we paid attention not to presuppose a great number of 
replicates, to ensure its applicability to typical dose-response designs. One perspective of this work will 
be to evaluate the impact of the number of concentrations on the workflow results, from data sets initially 
designed with more tested concentrations, in a purpose of design optimization. 
 
Recommendation regarding the use of the workflow 
At each step of the DRomics workflow, the user is free to choose several options (all the options tested 
within this work), both in the R package and the online version. However, we wish to provide some 
recommendations. For the selection step, the power of the ANOVA-based selection will increase with the 
number of replicates, which should not be favored in a concentration-response framework as explained 
before. In order to select only monotonic dose-response trends, a linear trend test may be a relevant 
choice. In contrast, a quadratic trend test proved efficient in our study where we wanted to select both 





(e.g. probes) is necessary not only to reduce the amount of information to be further processed (fitting and 
post-treatment/interpretation) but also to eliminate too noisy signals that may impair the quality and 
biological relevance of results
18
. We recommend the use of a selection step with a low FDR value (lower 
than 0.05 and ideally at 0.001) that ensures a good repeatability of the workflow results. For the choice of 
derived ECs, we already discussed a number of shortcomings regarding ECx (calculable only for sigmoid 
CRCs) and BMD-xfold which is equivalent to an ICx (hazardously sensitive to the control response 
level). We recommend using BMD-zSD that highlights a “critical” change compared to control, taking 
data variability into account. This approach has interesting features:  it is calculable whatever the 
concentration-response shape is and does not depend on the experiment design like does the 
NOEC/LOEC. Instead of choosing x for ECx or BMD-xfold, one has to choose z for BMD-zSD, the 
number of SD considered as “critical” change. EFSA
12
 proposed to set z=1. Setting z=2 would define the 
“critical” change as the theoretical upper or lower bound of the 95% coverage interval of control data. 
Note that the corresponding xfold change can be calculated afterwards.  
 
 Contribution of DRomics outputs for ERA process 
In ERA, OMICs approaches are rarely used in a concentration-response framework but to compare 
responses between 2 different conditions (e.g. upstream vs. downstream). This kind of designs present a 
high interest for biomarkers identification
25
 or environmental monitoring
26,27
 but used in a concentration-
response framework, omics might also support regulatory issues (i.e. point of departure determination) 
and improve our mechanistical understanding regarding stressors impact on the biota. For example, some 
studies have already shown the interest of omics dose-responses for ERA by providing for example a 
metabolites effect index
28
 or to highlight proteins response dynamics to chemicals
6
. The outputs of the 
DRomics tool (e.g. BMD, typology, and sensitivity distribution of the probes) allow supporting those 
goals. The derivation of an EC from non-sigmoidal curves is also handled by other tools, such as the 
BMDExpress
8
 (with an ANOVA-based selection step) and PROAST (without any molecular data 





dedicated to typical concentration-response designs and so compatible with a low number of replicates 
per treatment. Moreover, DRomics ensures a more efficient selection of biphasic CRCs and a better 
description of them, with a non-negligible mean difference in AIC values of 3.09 (Figures S10 and S11). 
As a consequence, DRomics gives more repeatable results for such biphasic CRCs, and a more 
conservative BMD distribution (Figures S11 and S12) in comparison to BMDExpress which seems to 
underestimate BMD values for biphasic CRCs. 
Our tool provides as an output the cumulated distribution of the BMD of the data of interest (here 
probes, Figure 3). This sensitivity distribution echoes the species sensitivity distribution concepts and thus 
exemplifies a first step (among the various possibilities of the tool) toward the use of omics data in ERA. 
Effect concentrations could also be a common language between biological level and omics. That might 
promote the establishment of links between levels and support mechanistical understanding using for 
example the functional annotation of the data. In this context, the tool can run on any other type of data 
that can be fitted directly by least-square regression and do not require a normalization step or that have 
been adequately processed in advance (e.g. metabolome data). Thus, DRomics provides comparable 
management for various omics data and facilitates multi-omics analysis. In the future, this tool will also 
be able to process RNA-seq data for which we plan to adapt the two first steps of the workflow taking 
into account the nature of RNA-seq data
29
. It will thus offer a simple way to compare the results obtained 
from different genomics platforms and evaluate their respective biological relevance as done by Webster 
at al.
18
 in toxicogenomics. The developed procedure is now available both as an R package named 
DRomics (https://lbbe.univ-lyon1.fr/-DRomics-.html) and as an online Shiny application (http://lbbe-







Figure 1. Venn diagram of the probes selected by the quadratic trend test, linear trend test and ANOVA 
test methods based on the datasets composed of A) 5 replicates, B) 3 replicates and C) 2 replicates. The 
number N of probes selected by the quadratic trend test (resp. linear trend test and ANOVA test) methods 
are A) N= 13,182 (resp N= 5,790 and N= 8,755) with 5 replicates, B) N= 7,616 (resp. N= 1,692 and N= 







Figure 2. Illustration of various trends observed among the data set: selected data sets with corresponding 
best-fit models and associated percentages of CRCs for each shape : the Hill model with d c<  (coded 
H.inc for increasing - 0.8% of curves) or  d c>  (coded H.dec for decreasing - 0.6% of curves), the linear 
model with 0b >  (coded L.inc for increasing - 14.6% of curves) or 0b <  (coded L.dec for decreasing - 
12.0% of curves), the exponential model with 0e >  and 0b >  (coded E.inc.convex for increasing 
convex - 11.8% of curves) or 0e >  and 0b <  (coded E.dec.concave for decreasing concave - 9.4% of 





0b >  (coded E.dec.convex for decreasing convex - 3.4% of curves), the Gaussian-probit model with 
0f <   (coded GP.U for U-shape - 16.8% of curves) or  0f >  (coded GP.bell for bell-shape - 12.5% of 
curves) and the log-Gaussian-probit model with 0f <  (coded lGP.U for U-shape - 7.9% of curves) or 
0f >  (coded lGP.bell for bell-shape - 6.7% of curves). Fitted curves are reported in red against the 
observed response with replicates represented in open circles and means of replicates at each dose 









Figure 3. Cumulative distribution of probe sensitivities (BMD) provided and exported from the DRomics 
tool. The x axis represents the BMD values (here, in µg/L). The y axis represents the Empirical 










Table 1. Set of models where x represents the concentration, y the observed signal and Φ the Cumulative Distribution Function (CDF) of the 1 





Name Equation Parameters 
linear y d bx= +   b  slope  
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b (> 0)  shape parameter  
c  asymptotic signal for high concentrations  
d  mean signal at the control 
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b  shape parameter  
d  mean signal at the control 
e  shape parameter 
when 0e >  the CRC is increasing if 0b >  (decreasing if 
0b < )  with no asymptote for high concentrations  
when 0e <  the CRC is increasing if 0b <  (decreasing if 
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b  (> 0) shape parameter corresponding to standard deviation of 
the Gaussian part  
c  asymptotic signal for high concentrations  
d  asymptotic signal on the left of the CRC (reached at the 
control only for the Log-Gauss-probit model) 
e  (> 0) shape parameter corresponding to mean of the 
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f amplitude of the Gaussian part (U shape if 0f <  and 
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DRomics: a turnkey tool to support the use of the dose-response framework 
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S1) MATERIAL AND METHODS 
This section introduces the methods used to design the microarray and to assess the transcriptomics 
response of the chlorophyte Scenedesmus vacuolatus. 
 
Microarray design 
As no commercial microarray was available for S. vacuolatus a microarray was designed based on a 
former RNA sequencing experiment. In brief, synchronized cultures of the chlorophyte were challenged 
by 18 treatments of different stressors such as chemicals, high ionic concentrations, heat and nutrient 
deficiencies. Algae from these treatments were harvested at different steps of the cell cycle by 
centrifugation (22°C, 10 min, 3300 g). Total RNA was isolated from algal pellets using Trizol (Invitrogen 
Carlsbad, CA) according to the manufacturer’s instruction with minor modifications. Quality and quantity 
of the extracted RNA were analysed by a Nanodrop Spectrophotometer (ND-1000, Peqlab, Erlangen, 
Germany) and an Experion 
TM
 RNA Highsens Analysis Kit (BioRad). mRNA was isolated from total 
RNA extracts using the Dynabeads® mRNA purification kit (ThermoFischer, Germany) according to the 
manufacturer’s instructions resulting in 1.9 µg L
-1
 pooled mRNA from all exposure conditions. 
Preparation of cDNA library was conducted according to the manufacturer’s instruction of the Roche 454 
GS-FLX Titanium platform. Briefly, 0.5 µg pooled mRNA was converted to double-stranded cDNA 
using a cDNA synthesis system Kit and a cDNA Rapid Library Prep Kit (Roche) and sequenced 
afterwards using the Roche 454 GS-FLX Titanium platform. The sequencing resulted in 934,866 reads 
with a length of up to 400 bps. 97% of the reads could be assembled into 22,000 contigs using Newbler 
software
1
. Out of this data set 21,495 contigs were selected to design a 8X60 K microarray using eArray 
(Agilent Technologies, Böblingen, Germany). Remaining gaps on the array were filled randomly with 
already represented probes. The probes sequences and the related contigs are presented in an excel file. 
Genome information (cDNA sequences) have been deposited in NCBI’s Sequence Read Archive and are 
accessible through the SRA accession number PRJNA498405 
(https://www.ncbi.nlm.nih.gov/sra/PRJNA498405). 
S. vacuolatus exposure to triclosan and RNA extraction 
Synchronized cultures of the chlorophyte S. vacuolatus (Shih. et Krauss strain 211-15, culture collection 
Pringsheim (SAG Göttingen, Germany)) were grown in a sterile inorganic medium (pH 6.4) at 28°C by 
using a 14:10 h light:dark cycle
2
. Chlorophytes were exposed for 14 hours to seven concentrations (0.69, 
1.22, 2.15, 3.77, 6.63, 11.65, 20.47 µg/L) of triclosan (CalbioChem, Germany, CAS: 3380-34-5, purity of 
99.8 %) and one solvent control (final DMSO concentration of 0.1 %) for 5 replicates in 500mL flasks 
containing 10
6
 cells/mL. Concentrations were chosen according to pre-studies, using 7 concentrations of 
S2 
 
triclosan in the range of 0.69 – 20.5 µg/L covering a full concentration response curve from no inhibition 
to 100% inhibition of algal growth and revealing an EC50 of 6.6 µg/L. Additionally, the quality of 
exposure conditions was analysed revealing a recovery of triclosan in the media of 81% during the 
exposure duration of 14h. With a focus on mode-of-action-related responses in the transcriptome at low 
concentrations we chose an exposure range below the EC50 value, hence the two highest exposure 
concentrations (11.65 and 20.47 µg/L) were not considered for the transcriptome analysis.  
Two times 80 mL suspensions of triclosan-exposed cultures were then harvested by centrifugation (22°C, 
10 min, 3300 g). Culture pellets were resuspended in 500µL TRIZOL and stored at -80°C until further 
analysis. After cell lysis and RNA extraction using a FastPrep®24 homogenizer system (Biomedicals, 
Santa Ana, USA) and Phase LockTM Gele Tubes (5 Prime GmbH, Hamburg, Germany), total RNA was 
further purified using a RNeasy®Plant Mini Kit (Quiagen, Hilden, Germany) according to the 
manufacturer’s instructions. RNA quantity and quality were analyzed using a NanoDrop 
Spectrophotometer (ND-1000, Peqlab, Erlangen, Germany) revealing an absorption coefficient of 
260/280 nm of 1.9 on average, which is within the quality criteria for purity of extracted RNA of 1.8-2.1 
requested by the manufacturer.  
 
Microarray analysis 
In total, 40 microarrays were used in this study. The microarrays were disposed on 5 slides, meaning that 
each slide was composed of 8 microarrays (Figure S1).  On each slide, each microarray was associated to 
one of the different treatments (from the control to the highest concentration tested). Thus, each slide 
represented one replicate.  
Fifty ng of purified RNA were labeled using the Low Input Quick Amp Labeling Kit, one color (Agilent 
Technologies). Finally 40 µL cy3-labeled fragmented cRNA per sample were hybridized to each 
microarray for 17h at 65°C. Then, the 40 microarrays were washed and scanned, using an Agilent DNA 
Microarray scanner. Fluorescence intensities were extracted using the Agilent Feature Extraction 
software. One of the criteria used to assess the quality of microarray analysis was based on the spot 
finding at the four corners of the arrays (on image per array=40 images) and the Agilent SpikeIns 
concentration-response. Quality criteria were satisfying for each array (Table S1). The fluorescence data 
have been deposited in NCBI’s Gene Expression Omnibus
3
 and are accessible via GEO Series accession 













Figure S1: Microarray experimental design.  
 
Table S1. Quality control metrics related to each microarray included in the tool development (=without 
2.2 and 2.3, the two highest concentrations). For array numbers, 1.1:  concentration 1; 1.2: concentration 
2; 1.3: concentration 3; 1.4: concentration 4; 2.1: concentration 5, 2.4: control).  
Slide Array Aligned to grid  SpikeIns Slope SpikeIns R² 
1 1.1 1 1.08 1 
  1.2 1 1.05 0.99 
  1.3 1 1.07 1 
  1.4 1 1.07 0.99 
  2.1 1 1.08 1 
  2.4 1 1.1 0.99 
2 1.1 1 1.07 0.99 
  1.2 1 1.08 1 
  1.3 1 1.08 1 
  1.4 1 1.05 0.99 
  2.1 1 1.09 0.99 
  2.4 1 1.05 0.99 
3 1.1 1 1.09 1 
  1.2 1 1.07 0.99 
  1.3 1 1.05 0.99 
  1.4 1 1.06 1 
  2.1 1 1.07 0.99 
  2.4 1 1.09 0.99 
4 1.1 1 1.08 1 
  1.2 1 1.04 1 
  1.3 1 1.08 1 
  1.4 1 1.06 1 
  2.1 1 1.08 1 
  2.4 1 1.06 1 
5 1.1 1 1.05 0.99 
  1.2 1 1.06 0.99 
  1.3 1 1.04 0.99 
  1.4 1 1.06 1 
  2.1 1 1.07 1 
  2.4 1 1.08 1 
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S2) COMPARISON OF INTER-ARRAY NORMALIZATION METHODS  
Here, are presented the graphical outputs (also provided in the DRomics tool) of the normalization step 
for each proposed method. 
 
Figure S2. Boxplots of fluorescence values (in log2) for each array, before and after normalization by 





S3) DESCRIPTION OF THE BIPHASIC MODELS 
Description of the 5-parameter Gauss-probit and log-Gauss-probit models. 
The 5-parameter Gauss-probit model is defined as the sum of a Gauss part and a probit part as illustrated 
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See also Table 1 of the manuscript for parameter description. 
From this formulation one can calculate its first derivative as below: 
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 The Gauss-probit model thus describes a biphasic model if 0f ≠ , with the maximum (if 0f >  ) or the 






= + . 
The log-Gauss-probit model is the same model in log-scale, obtained by replacing x  by ( )ln x  and e  by
( )ln e : 
( ) ( ) ( ) ( ) ( )
2
ln ln ln ln1
exp
2
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It is thus also a biphasic model if 0f ≠ , with the maximum (if 0f >  ) or the minimum (if 0f <  ) 





















Figure S3. Schematic description of the 5-parameter Gauss-Probit model, as an addition of a Gaussian 
part and a probit part, with realistic values of parameters (such as some encountered in our data sets):












S4) MODELLING COMPLEMENTARY RESULTS 
This part presents complementary results for the modelling step: examples of probes first 
selected in the selection step and secondly eliminated in the modelling step (Figure S4) and the 
fit of the concentration-response curve for the first 49 probes selected (Figure S5). 
 
 
Figure S4. Typical examples of probes first selected in the selection step and secondly eliminated in the 
modelling step: a very noisy data set (on the left) and a data set for which the significant response was 





Figure S5. Fit of the concentration-response curve for the first 49 probes selected (ordered by decreasing 
adjusted p-values). Fitted curves are reported in red against the observed response with replicates 
represented in open circles and means of replicates at each dose represented by solid circles. 
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S5) BMD DERIVATION 
This part exemplifies how the control level influences the value of the derived BMD-xfold 
(Figure S6) and illustrates the calculation of the BMD on a biphasic model (Figure S7).  
 
 
Figure S6. Illustration of BMD-10%fold. Both probes are modelled by linear CRCs with the same slope 
but different intercept (y0). A situation with a low y0 value (A) leads to a lower BMD-xfold value than a 








Figure S7. Illustration of situations where the BMD-1SD is found before the model extremum (on the 





S6) CUMULATIVE DISTRIBUTION OF PROBE SENSITIVITIES PER TYPOLOGY 
Presentation of one of the graphical output of the DRomics tool based on the BMD values of 
all the probes selected by the previous steps of the workflow. 
  
  
Figure S8. Distribution of the BMD-zSD values (with z = 1) of each probe associated specifically to each 






S7) ILLUSTRATION OF TYPES OF DISCORDANCES IN THE REPEATABILITY 
STUDY 
The following figure gives examples of rare probes for which a great discordance was 
observed between both replicates.  
 
 





S8) COMPARISON OF DROMICS AND BMDEXPRESS RESULTS  
BMDExpress is often used to model dose-response curves for omics data and to derivate BMD values. 
Therefore, we compared DRomics and BMDExpress results on the same data set. We especially 
compared their ability to describe observed responses (using AIC values), BMD values and their 
repeatability. For that purpose, we ran BMDExpress on a subset of 1814 probes (= 2*907), corresponding 
to 907 probes that were replicated and both selected using an FDR value of 0.001. For this set of samples, 
we used BMDExpress for the modelling and BMD calculation step. A value of a BMR of 1 SD was used 
in order to obtain BDM values comparable to DRomics BMD-1SD values. As BMDExpress is far more 
time consuming than DRomics, it is necessary using BMDExpress to properly define options to optimize 
the calculation on the used computer. Using a Toshiba Portege laptop (Intel Core i7 with 4 cores, 2.5 
GHz, 8GB RAM, Windows 7 pro) we fixed the number of threads to 16 (four times the number of 
available cores on the computer, as recommended in the online tutorial) and kept the model execution 
time out at its default value of 600 seconds (it corresponds to the maximal time the software can run a 
model for an individual probe).  Using those parameters, the run of BMDExpress on the subset of data 
took around two hours while it took around one minute using the DRomics package with the parallel 
computation implemented in the modelling step. 
BMDExpress was used with its default choice of proposed models: linear, Hill, power, exponential and 
second and third order polynomial models. BMDExpress and DRomics provided the AIC value for each 
fitted model and the best AIC value (AIC value of the chosen model) for each CRC. As AIC values are 
calculated up to a constant, those AIC values were put on the same scale by equalling AIC values of the 
linear model given by both tools.  We can see on Figure S10 that if best AIC values are rather similar for 
responses characterized by DRomics as monotonic (“inc” or “dec” DRomics trend), a great number of 
responses characterized by DRomics as biphasic (“U” or “bell” DRomics trend) are better fitted by 
DRomics, with a smaller AIC value. For 4.43% (resp. 0.52%) of the probes, the best model proposed by 
BMDExpress revealed a higher (resp. lower) AIC than the one proposed by DRomics (absolute difference 
in AIC greater than 10). The mean differences of AIC values (BMDExpress – Dromics) is of 0.955, with 
a great heterogeneity due to trend of responses: the models chosen by BMDExpress reveal slightly lower 
AICs than by DRomics for monotonic responses (mean difference in AIC of - 0.38) but higher AICs for 




Figure S10. Scatter plot of AIC values of the best model chosen by DRomics (x-axis) and BMDExpress 
(y-axis), with the color of each point coding for the trend of the CRC as characterized by DRomics. 
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Figure S11 corresponds to the scatter plot of BMD values estimated by DRomics (x-axis) and 
BMDExpress (y-axis). We can see on this plot that the tools gave well correlated values for monotonic 
CRCs, but not for biphasic responses, for which DRomics tends to give smaller BMD values. It seems 
that BMDExpress, which only proposes second and third polynomial models as non-monotonic models, 
has some difficulties to describe biphasic CRCs. DRomics made the choice of a biphasic model 6.4 times 
more than BMDExpress on this subset of data. This difficulty has a clear consequence on the BMD 
distribution (Figure S12) as BMDExpress may overestimates BMD values for biphasic CRCs. 
 
Figure S11. Scatter plot of the BMD-1SD values estimated by DRomics (x-axis) and BMDExpress (y-





Figure S12. Distribution of the BMD-1SD values as estimated by DRomics (left) and by BMDExpress 
(right). 
 
Concerning the repeatability of the results obtained per probe, the method described in part “Repeatability 
of the results” in the main manuscript was also applied to BMDExpress on the subset of data. The 
repeatability of BMDExpress was globally lower than the one of DRomics, based on values of root mean 
square error (RMSE: root mean squared differences between BMD-1SD values estimated for both 
replicates of each probe) of 0.882 for DRomics and 1.215 for BMDExpress. DRomics gave a slightly 
higher RMSE for biphasic responses (1.079) than for monotonic responses (0.733) while BMDExpress 
gave less repeatable results for probes with a biphasic response (respective RMSE values of 1.803 and 
0.615). This last result confirms the difficulty to give a relevant and repeatable estimation of the BMD 





(1)  Kumar, S.; Blaxter, M. L. Comparing de Novo Assemblers for 454 Transcriptome Data. 
BMC Genomics 2010, 11 (1), 571. 
(2)  Altenburger, R.; Walter, H.; Grote, M. What Contributes to the Combined Effect of a 
Complex Mixture? Environ. Sci. Technol. 2004, 38 (23), 6353–6362. 
(3)  Edgar, R. Gene Expression Omnibus: NCBI Gene Expression and Hybridization Array 
Data Repository. Nucleic Acids Res. 2002, 30 (1), 207–210. 
 
